Pharmaceutical care of a patient with type 2 diabetes and osteoporosis
10.12206/j.issn.2097-2024.202110024
- VernacularTitle:1例2型糖尿病伴骨质疏松患者的药学监护
- Author:
Jinqian LUO
1
;
Songwei LU
1
;
Jing TIAN
1
;
Huihua YU
1
Author Information
1. Department of Pharmacy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
- Keywords:
diabetes;
osteoporosis;
diabetic osteoporosis;
chronic disease medication management;
pharmaceutical care
- From:
Journal of Pharmaceutical Practice and Service
2022;40(5):473-476
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the disease characteristics and key factors of pharmaceutical care in patients with diabetes and osteoporosis, and provide references for clinical rational and effective medication. Methods Clinical pharmacist participated in the drug analysis of a patient with type 2 diabetes and osteoporosis. The pharmaceutical recommendations were proposed to assist physicians in optimizing the treatment plan, combined with the patient’s disease characteristics and pathological characteristics. Results After the reorganization of the treatment plan and pharmaceutical care, the patient's treatment effect had been significantly improved. Conclusion The pathogenesis of diabetic osteoporosis is complex. The current treatment is based on hypoglycemic combined with anti-osteoporosis drugs. Through chronic disease drug management and pharmaceutical monitoring, rational drug use could be promoted.
